Medtronic has removed its Sprint Fidelis defibrillation leads from the market after several adverse events in patients. Defibrillators are used to monitor the heart rate in patients. If the defibrillator detects an irregular heart rhythm, it sends an electrical shock to the heart to restore normal rhythm. Medtronic has found that the leads are prone to fracture. These fractures may cause the lead to deliver unnecessary shocks to the heart or not operate at all. Due to the problems with the leads, Medtronics has requested that doctors stop implanting the leads and return all unused leads to Medtronic. If you or a loved one has been injured by an implanted defibrillator, you may be entitled to compensation. Please contact the attorneys at Sheller, P.C. to discuss your legal rights. We have a team of experienced trial attorneys who can use their expertise to help you.
For more information on this subject, please refer to the section on Drugs, Medical Devices, and Implants.
The Legal Examiner and our Affiliate Network strive to be the place you look to for news, context, and more, wherever your life intersects with the law.
Comments for this article are closed.